Ceritinib treated a Omsal inhibitor and tamsulosin example primarily metabolized by CYP3A4. Vemurafenib is an inducer of CYP3A4 and decreased plasma concentrations of drugs metabolized by this enzyme, such as tamsulosin, could be expected with concurrent use.
Possible side effects of Omsal include:
Omsal is used to treat diseases such as: Benign Prostatic Hyperplasia, Overactive Bladder, Urinary Tract Stones.
Do not take more than two doses in one day. If daily doses exceed 4 g, there is an increased risk of GI adverse effects.